Novo Nordisk | Pharma 50
Novo Nordisk Pharmatech - Pharma Technology Focus | Yearbook 2018
Novo Nordisk plans $2.6bn pharma build with engineering partner NNE
Novo Nordisk to build €70m plant in Iran | Financial Times
Novo Nordisk reaches $3.3B deal to acquire RNAi partner Dicerna Pharma - MedCity News
Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds | Fierce Pharma
Novo Nordisk's membership suspended by UK pharma trade group over obesity drug marketing breach
Novo Nordisk invests US$2.6 billion to ramp up manufacturing capabilities | HealthCare Middle East & Africa Magazine
Novo Nordisk (@novonordisk) / Twitter
Novo Nordisk leads pharma pack breaking into Reputation Institute's corporate responsibility ranking | Fierce Pharma
Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
Novo Nordisk: This Winner Has Risks, Be Aware (NYSE:NVO) | Seeking Alpha
Novo Nordisk | Contract Pharma
Novo Nordisk Suspended by UK Pharma Group Over Saxenda Weight-Loss Marketing - Bloomberg
Wegovy, the newest weight loss drug, comes with a high cost - Los Angeles Times
Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases | Business Wire
Fluor to Build Huge NC Pharma Plant for Novo Nordisk - Commercial Property Executive
Novo Nordisk vows to limit price hikes, stepping up pressure on its pharma rivals | Fierce Pharma
Novo Nordisk drug semaglutide demonstrates weight loss in obese adults
Novo Nordisk U.S. Headquarters in Plainsboro, NJ | Novo Nordisk U.S.
